Trial Parameters
Brief Summary
The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 30 days. The subjects will complete questionnaires throughout the study at pre-specified timepoints.
Eligibility Criteria
Inclusion Criteria: * Male or female. * Age 25-59 years. * BMI ≥18.5 and ≤29.9 kg/m². * Currently experiencing issues with sleep quality, falling asleep, staying asleep, or waking during the night. * RU-SATED score ≤17. * Willing and able to follow the study protocol. * Willing to discontinue any other supplements (including nootropics, adaptogens, calming herbs), medications, herbal remedies, or over-the-counter sleep medications (e.g., zolpidem, diphenhydramine, Benadryl, ZzzQuil, Unisom, magnesium or melatonin products) used to assist with sleep during the study. * Agree to limit alcohol intake within approximately 4 hours of bedtime throughout participation. * Agree to limit caffeine intake to ≤400 mg/day (about 3-4 cups of coffee) and avoid ingestion of caffeine-containing products after 2:00 PM during the study period. * Generally healthy and not living with any uncontrolled chronic disease. * Resides in the United States. * Willing to discontinue any restricted products and adhe